Literature DB >> 11807695

ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

Srdjan Jelacic1, Cheryl L Wobbe, Daniel R Boster, Marcia A Ciol, Sandra L Watkins, Phillip I Tarr, Ann E Stapleton.   

Abstract

P1 and ABO antigens and bacterial stx genotypes might influence the risk of developing hemolytic uremic syndrome (HUS) after Escherichia coli O157:H7 infections. We determined ABO status and P1 antigen expression in 130 infected and 17 uninfected children, and we determined the stx genotype of the infecting isolate. P1 expression was weakly and directly related to HUS risk (P=.04), but this risk did not extend to the group with the greatest P1 expression. P1 expression remained constant as HUS evolved. The ABO frequency was similar in all groups. These associations were not affected by the stx genotype. stx1(-)/stx2(+) E. coli O157:H7 strains were more commonly associated with HUS than were stx1(+)/stx2(+) strains (P=.21), and 1 child with HUS was infected with a rare stx1(+)/stx2(-) isolate. In the present study, ABO antigens and stx genotypes were not major determinants of the outcome of E. coli O157:H7 infections, and P1 expression did not protect against the development of HUS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807695     DOI: 10.1086/338480

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.

Authors:  Ryan S McKee; David Schnadower; Phillip I Tarr; Jianling Xie; Yaron Finkelstein; Neil Desai; Roni D Lane; Kelly R Bergmann; Ron L Kaplan; Selena Hariharan; Andrea T Cruz; Daniel M Cohen; Andrew Dixon; Sriram Ramgopal; Annie Rominger; Elizabeth C Powell; Jennifer Kilgar; Kenneth A Michelson; Darcy Beer; Martin Bitzan; Christopher M Pruitt; Kenneth Yen; Garth D Meckler; Amy C Plint; Stuart Bradin; Thomas J Abramo; Serge Gouin; April J Kam; Abigail Schuh; Fran Balamuth; Tracy E Hunley; John T Kanegaye; Nicholas E Jones; Usha Avva; Robert Porter; Daniel M Fein; Jeffrey P Louie; Stephen B Freedman
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro.

Authors:  Ilze Matise; Nancy A Cornick; James E Samuel; Harley W Moon
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

6.  Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.

Authors:  Nurmohammad Shaikh; Phillip I Tarr
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

7.  Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity.

Authors:  Beatriz Quiñones; Shane Massey; Mendel Friedman; Michelle S Swimley; Ken Teter
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

8.  Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.

Authors:  G A M Tarr; S Shringi; H N Oltean; J Mayer; P Rabinowitz; J Wakefield; P I Tarr; T E Besser; A I Phipps
Journal:  Epidemiol Infect       Date:  2018-06-19       Impact factor: 4.434

9.  Genome Sequence of Escherichia coli O157:H7 Strain 2886-75, Associated with the First Reported Case of Human Infection in the United States.

Authors:  Fatemeh Sanjar; Tracy H Hazen; Sadiq M Shah; Sara S K Koenig; Sonia Agrawal; Sean Daugherty; Lisa Sadzewicz; Luke J Tallon; Mark K Mammel; Peter Feng; Robert Soderlund; Phillip I Tarr; Chitrita Debroy; Edward G Dudley; Thomas A Cebula; Jacques Ravel; Claire M Fraser; David A Rasko; Mark Eppinger
Journal:  Genome Announc       Date:  2014-01-09

10.  Mild Illness during Outbreak of Shiga Toxin-Producing Escherichia coli O157 Infections Associated with Agricultural Show, Australia.

Authors:  Bhakti R Vasant; Russell J Stafford; Amy V Jennison; Sonya M Bennett; Robert J Bell; Christine J Doyle; Jeannette R Young; Susan A Vlack; Paul Titmus; Debra El Saadi; Kari A J Jarvinen; Patricia Coward; Janine Barrett; Megan Staples; Rikki M A Graham; Helen V Smith; Stephen B Lambert
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.